India Blood Testing Market Size, Share, and COVID-19 Impact Analysis, By Test Type (Vitamin D testing, Thyroid-stimulating hormone testing, AST testing, Glucose testing, A1C testing, Lipid panel testing, Prostate-specific antigen testing, High sensitivity CRP testing, Direct LDL testing, BUN testing, Serum Nicotine/Cotinine testing, Cortisol testing, Creatinine testing, COVID-19 testing, Testosterone testing, ALT testing, and Other blood tests), and India Blood Testing Market, Insight, Industry Trend, Forecasts to 2035

India Blood Testing Market Insights Forecasts to 2035

• India Blood Testing Market Size 2024: USD 3190.09 Million
• India Blood Testing Market Size 2035: USD 7880.27 Million
• India Blood Testing Market CAGR: 8.57%
• India Blood Testing Market Segments: Test Type

Blood testing refers to a medical diagnostic test that requires the evaluation of a blood sample to determine the health status of an individual and identify possible diseases. The test requires the analysis of blood components such as red and white blood cells, platelets, glucose, cholesterol, hormones, enzymes, and electrolytes. Blood testing is commonly used in the diagnosis of infections, diabetes, cardiovascular diseases, anemia, and liver or kidney disorders. The test can also be used in health screenings, managing chronic diseases, measuring the effectiveness of treatments, and promoting preventive healthcare.

The Indian government and health organizations have developed policies and initiatives to increase access to diagnosis, improve surveillance of diseases, and improve overall healthcare outcomes. Routine blood tests are now a part of preventive health check-ups and subsidized screening programs for diseases such as diabetes, anemia, and cardiovascular disease in many national health care systems. Public health initiatives and investments have also helped in widespread screening during health crises, including infectious disease outbreaks such as COVID-19. In India, policies have been developed to ensure quality in laboratories through accreditation and proficiency testing to ensure accuracy in blood diagnostics.

MedGenome launched MetaSeq, a metagenomic next-generation sequencing blood test that analyzes microbial cell-free DNA to detect bloodstream infections. It identifies over 1,400 pathogens, including bacteria, fungi, parasites, and DNA viruses, offering faster, comprehensive diagnosis without multiple targeted assays. Amazon India is piloting a home sample collection service, allowing customers to schedule pickup of blood and urine samples for lab testing. This initiative integrates healthcare convenience with Amazon’s logistics, aiming to simplify diagnostics access and expand its footprint in India’s health-tech ecosystem.

Market Dynamics of the India Blood Testing Market:

The India Blood Testing Market Size is growing progressively due to several growth drivers in the healthcare systems of India. The main driver of the market is the increasing incidence of chronic conditions such as diabetes, cardiovascular diseases, cancer, and infections. There is an increase in awareness about health among people, and the trend of preventive healthcare is also contributing to the growth of the blood testing market. The need for health check-ups is also contributing to the growth of the blood testing market. There is an increase in the number of home sample collection service providers.

The India Blood Testing Market Size is restrained by the cost of advanced diagnostic technologies, which may be a challenge to the blood testing market, especially in low- and middle-income countries. Moreover, inadequate lab facilities in rural areas, a lack of qualified professionals, and issues related to data privacy may be restraining factors for the blood testing market.

The India Blood Testing Market Size is experiencing strong opportunities due to the growing adoption of at-home testing, telemedicine, and the demand for preventive healthcare. The adoption of AI-based data analytics and personalized medicine is improving the accuracy of diagnoses and tailoring treatments to individual patients. The trends in the blood testing market include point-of-care testing, minimally invasive sampling methods, digital reporting systems, and investments in molecular and genomic testing, which are changing the face of conventional laboratory models.

Market Segmentation

The India Blood Testing Market share is classified into test type.

By Test Type:

The India Blood Testing Market Size is divided by testing type into vitamin D testing, thyroid-stimulating hormone testing, AST testing, glucose testing, A1C testing, lipid panel testing, prostate-specific antigen testing, high sensitivity CRP testing, direct LDL testing, BUN testing, serum nicotine/cotinine testing, cortisol testing, creatinine testing, COVID-19 testing, testosterone testing, ALT testing, and other blood tests. Among these, the glucose testing segment controlled the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The glucose testing segment dominated due to o the rising prevalence of diabetes and prediabetes across the country. India has one of the largest diabetic populations globally, leading to continuous demand for routine blood glucose monitoring for diagnosis and disease management.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the India Blood Testing Market Size, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

Top Key Companies in India Blood Testing Market:

• Apollo Diagnostics
• Dr. Lal PathLabs
• MedGenome Labs
• Metropolis Healthcare
• Neuberg Diagnostics
• Oncquest Laboratories
• SRL Diagnostics
• Suburban Diagnostics
• Thyrocare Technologies
• Vijaya Diagnostic Centre
• Others

Recent Developments in India Blood Testing Market:

In February 2026, Torrent Group launched Torrent Diagnostics in Navi Mumbai, establishing India’s largest national reference laboratory. Spanning 100,000 sq ft, it offers 3,500+ tests across 15 disciplines, equipped with NGS, MALDI-TOF, and BSL-3 facilities, signaling a technology-driven entry into India’s competitive blood testing market.

In February 2026, Biovet, a subsidiary of Bharat Biotech, secured approval from the Central Drugs Standard Control Organization for BIOLUMPIVAXIN, the world’s first DIVA marker vaccine for lumpy skin disease in cattle and buffaloes, strengthening India’s indigenous veterinary vaccine development and disease surveillance capabilities.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the India, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the India Blood Testing Market Size based on the below-mentioned segments:

India Blood Testing Market, By Test Type

• Vitamin D testing
• Thyroid-stimulating hormone testing
• AST testing, Glucose testing
• A1C testing, Lipid panel testing
• Prostate-specific antigen testing
• High sensitivity CRP testing
• Direct LDL testing
• BUN testing
• Serum Nicotine/Cotinine testing
• Cortisol testing
• Creatinine testing
• COVID-19 testing
• Testosterone testing
• ALT testing
• Other blood tests